This is the authors' abstract. We don't add key points for this paper.
The synthesis of quinuclidine and azanorbornyl pyrazine derivatives has yielded highly potent and efficacious muscarinic agonists; chloro-substitution in the pyrazine ring of the quinuclidine analogue resulted in the formation of a derivative with both enantiomers displaying partial agonist character but, more importantly, functional selectivity at the M1, M2 and M3 sub-types of the muscarinic receptor.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: